NGX-4010 for the Treatment of Postherpetic Neuralgia

Completed · Phase 2/Phase 3

Conditions studied: Herpes Zoster, Neuralgia, Pain, Peripheral Nervous System Diseases, Shingles

In brief

The purpose of the study is determine if an investigational drug, NGX-4010 (high-concentration capsaicin dermal patches) is effective in treating pain associated with post-herpetic neuralgia (PHN).

Key facts

Study ID

NCT00061776

Run by

NeurogesX

People needed

300

Last updated by the study team

2008-03-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• NeurogesX Investigational Site — Huntsville, Alabama, United States
• NeurogesX Investigational Site — Phoenix, Arizona, United States
• NeurogesX Investigational Site — Scottsdale, Arizona, United States
• NeurogesX Investigational Site — Tucson, Arizona, United States
• NeurogesX Investigational Site — Little Rock, Arkansas, United States
• NeurogesX Investigational Site — La Jolla, California, United States
• NeurogesX Investigational Site — San Francisco, California, United States
• NeurogesX Investigational Site — Denver, Colorado, United States
• NeurogesX Investigational Site — Melbourne, Florida, United States
• NeurogesX Investigational Site — Naples, Florida, United States
• NeurogesX Investigational Site — Ocala, Florida, United States
• NeurogesX Investigational Site — Palm Beach Garden, Florida, United States
• NeurogesX Investigational Site — Plantation, Florida, United States
• NeurogesX Investigational Site — Sarasota, Florida, United States
• NeurogesX Investigational Site — St. Petersburg, Florida, United States
• NeurogesX Investigational Site — Boston, Massachusetts, United States
• NeurogesX Investigational Site — Kansas City, Missouri, United States
• NeurogesX Investigational Site — Las Vegas, Nevada, United States
• NeurogesX Investigational Site — Morristown, New Jersey, United States
• NeurogesX Investigational Site — Albany, New York, United States
• NeurogesX Investigational Site — Rochester, New York, United States
• NeurogesX Investigational Site — Eugene, Oregon, United States
• NeurogesX Investigational Site — Memphis, Tennessee, United States
• NeurogesX Investigational Site — Austin, Texas, United States
• NeurogesX Investigational Site — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.